Compound Profiles
Adipotide
Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity
CKGGRAKDC ligand homes to prohibitin/annexin A2 on white-fat endothelium; linked D-(KLAKLAK)2 disrupts mitochondrial membranes post-internalization, triggering localized endothelial apoptosis and adipocyte loss..
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Adipotide with BPC-157?
Yes, Adipotide and BPC-157 can generally be taken together. No known direct interaction; distinct mechanisms and targets.
Is Adipotide and BPC-157 safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Adipotide and BPC-157?
No known direct interaction; distinct mechanisms and targets. This assessment has 90% confidence and is based on documented research data.
How should I time Adipotide and BPC-157?
Adipotide has a half-life of Not established and BPC-157 has a half-life of <30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.